You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Laboratoire Gifrer - Dacudoses & Novoptine (Divestiture, in 2019)

Transaction #122331
Investor
1
Sign up to view
Target Company
Laboratoire Gifrer - Dacudoses & Novoptine
Life Science · France
Seller
1
Sign up to view
04 Jul 2019
Announced
Target Company
Company Sector Entity Type Status State Country
Laboratoire Gifrer - Dacudoses & Novoptine Life Science Private Active — France
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Laboratoire Gifrer - Dacudoses & Novoptine acquisition deal?
This transaction is an acquisition of Laboratoire Gifrer - Dacudoses & Novoptine (Divestiture) in 2019. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Laboratoire Gifrer - Dacudoses & Novoptine acquisition happen?
This transaction was announced on 04 Jul 2019.
What is the deal value of the Laboratoire Gifrer - Dacudoses & Novoptine acquisition?
Deal value information for this transaction is available on AcquityData.
Who are the investors in the Laboratoire Gifrer - Dacudoses & Novoptine transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Laboratoire Gifrer - Dacudoses & Novoptine deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial